Additionally, research on combination therapies involving endostatin has emerged, such as combining it with chemotherapy agents like cyclophosphamide in colon cancer treatment, which demonstrated an additive effect on tumor inhibition and microvessel count (5). This evidence concerns the gene COL18A1 and neoplasm.